Home / Recalls / HOSPIRA INC, LAKE FOREST / D-1082-2017

D-1082-2017 Class II Terminated

Recalled by HOSPIRA INC, LAKE FOREST — LAKE FOREST, IL

Recall Details

Product Type
Drugs
Report Date
August 16, 2017
Initiation Date
July 26, 2017
Termination Date
May 11, 2018
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
56,340 vials

Product Description

Hydromorphone Hydrochloride Injection, USP, 50 mg/5 mL (10 mg/mL), 5 mL Single Dose Vial.(10 vials per carton NDC 0703-0113-01) and 180 vials per case (NDC 0703-0113-03) Mfd By: Hospira, Inc., Lake Forest, IL 60045 USA, Mfd For: Teva Parenteral Medicines, Inc., Irvine, CA 92618 USA.

Reason for Recall

Presence of Particulate Matter: Silicone oil

Distribution Pattern

Nationwide in the USA

Code Information

Lot #: 560103F, Exp. 01AUG2017

Other recalls by HOSPIRA INC, LAKE FOREST

  • D-0906-2018 Class I — Naloxone Hydrochloride Injection, USP, 0.4 mg/mL, 1 mL in 2.5 mL Carpuject Singl (June 4, 2018)
  • D-1080-2017 Class II — Hydromorphone Hydrochloride Injection, USP, 500 mg/50 mL (10 mg/mL), 50 mL Singl (July 26, 2017)
  • D-1081-2017 Class II — Hydromorphone Hydrochloride Injection, USP, 500 mg/50 mL (10 mg/mL), 50 mL Singl (July 26, 2017)